Searched for
ABEVMY
Biocon Biologics completes integration of Viatris' biosimilar business in 120 countriesThe company said over 10 emerging markets along with Japan, Australia and New Zealand have transitioned in this final phase of the integrat...- Market movers: LIC shareholders lose Rs 77K crore in four days; Paytm gets 4% lift ahead of Q4 showLIC stock has fallen 13 per cent from its issue price of Rs 949 to Rs 826. In that process, shareholders of the company have lost over Rs 7...
- Biocon climbs 4% as pharma giant’s arm launches cancer treatment product AbevmyBiocon’s share price climbed to a high of Rs 334.70 as against Rs 322.95 at previous close on the BSE.Abevmy is a recombinant humanized mon...
- Stocks in the news: NTPC, Wipro, HPCL, Ashok Leyland, V-Guard and ConcorNTPC, Thermax, Paytm, Zydus Lifesciences, Indigo Paints, IRFC, Pfizer, Metro Brands, Narayana Hrudayalaya, Nuvoco Vistas, Sobha, IDFC, Amaj...
- Biocon Biologics, Viatris receive approval for cancer drugAbevmy is approved for treatment in metastatic colorectal carcinoma, metastatic breast cancer, non small-cell lung carcinoma, glioblastoma,...
- Biocon Biologics, Viatris Inc. get CHMP nod for Abevmy, a biosimilar to AvastinAbevmy is abiosimilar to Roche's Avastin, prescribed for all indications including metastatic colorectal carcinoma, metastatic breast cance...
Load More